Informationen:
Fehler:
ID
39391
Beschreibung
Feasibility Study of an Integrated Diagnostic System to Manage Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01045343
Link
https://clinicaltrials.gov/show/NCT01045343
Stichworte
Versionen (1)
- 06.01.20 06.01.20 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
6. Januar 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Heart Failure NCT01045343
Eligibility Heart Failure NCT01045343
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Heart Failure NCT01045343
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Informed Consent
Item
subject is willing and able to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
subject is at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Protocol Compliance
Item
subject is willing and able to comply with the clinical investigation plan
boolean
C0525058 (UMLS CUI [1])
Enrollment Network Specified
Item
subject is currently enrolled in the medtronic carelink® network
boolean
C1516879 (UMLS CUI [1,1])
C1882071 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C1882071 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
Heart failure New York Heart Association Classification | Hospitalization Due to Heart Failure
Item
subject is currently a new heart association (nyha) functional class iii or nyha functional class ii with a heart failure related hospitalization within the past 180 days
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C3898876 (UMLS CUI [2])
C1275491 (UMLS CUI [1,2])
C3898876 (UMLS CUI [2])
Implantation of CRT-D Specified
Item
subject has a medtronic concerto®/consulta® cardiac resynchronization therapy (crt)device implanted for at least 180 days
boolean
C1135480 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,2])
Diuretic therapy Oral Daily | Management Heart failure
Item
subject has been prescribed daily oral diuretic therapy for the management of heart failure
boolean
C0948575 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
C0376636 (UMLS CUI [2,1])
C0018801 (UMLS CUI [2,2])
C1527415 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
C0376636 (UMLS CUI [2,1])
C0018801 (UMLS CUI [2,2])
Study Subject Participation Status | Clinical Trial | Exception Clinical Trial Approved
Item
subject is enrolled in a concurrent study with the exception of a study approved by the indicate hf clinical trial leader
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0008976 (UMLS CUI [3,2])
C0205540 (UMLS CUI [3,3])
C0008976 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0008976 (UMLS CUI [3,2])
C0205540 (UMLS CUI [3,3])
Life Expectancy
Item
subject has a life expectancy of less than 1 year
boolean
C0023671 (UMLS CUI [1])
CRT-D Battery Duration
Item
subject's crt device has an estimated battery life of less than 2 years
boolean
C1135480 (UMLS CUI [1,1])
C1704779 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C1704779 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])